- Activation of ~4,000 genes involved in tissue remodeling
- Stimulation of collagen I, III, and elastin synthesis in fibroblasts
- Inhibition of MMP-1 metalloproteinase (collagen degradation)
- Antioxidant and anti-inflammatory properties
- VEGF and FGF upregulation (angiogenesis and healing)
GHK-Cu (Péptido de Cobre)
Also known as: Tripéptido de cobre, Copper Peptide, Glycyl-L-histidyl-L-lysine
GHK-Cu (Glycyl-L-histidyl-L-lysine copper) is a copper tripeptide that occurs naturally in human blood plasma, saliva, and urine. Plasma concentrations decrease significantly with age (~200 ng/mL at age 20 vs. ~80 ng/mL at age 60). Widely used in clinical cosmetics and under investigation in regenerative medicine.
Mechanism of action
Uses & indications
- Dermal anti-aging: Wrinkle reduction, improved skin firmness and elasticity
- Accelerated wound healing and chronic ulcers
- Alopecia: Hair growth stimulation
- Connective tissue repair (tendons, bones)
Effects
Positive effects: Widely documented in cosmetics (multiple RCTs). Reduction of fine wrinkles within 12 weeks of topical use, improved hair density.
Adverse effects: Minimal. Mild skin irritation at high concentrations (>5% topical). Risk of copper toxicity with excessive systemic use (theoretical).
Considerations & contraindications
- Not approved as a drug (FDA/EMA)
- Widely regulated as a cosmetic ingredient (INCI: Copper Tripeptide-1)
- Caution with excessive systemic copper supplementation (Wilson's disease)
Regulatory approval
Dosage
Storage
Technical data
Categories
If you detect incorrect information, tell us what is wrong and provide a scientific source to support it.